by AIP Online Bureau | Dec 23, 2025 | Data, Health
Afrezza is a rapid-acting orally inhaled insulin, which offers a needle-free, convenient alternative to injectable insulin therapy. The launch of this product in India is expected to benefit many of the 10 crore adults currently living with diabetes mellitus....
by AIP Online Bureau | Aug 23, 2025 | Eco/Invest/Demography, Health, Indian News, Policy
“Our ultimate goal should be universal healthcare. While India has progressed, disparities persist. We need strong ethical practices and regulatory courage, particularly in drug pricing and hospital costs, to make healthcare equitable,” Dr DS Rana,...
by AIP Online Bureau | Mar 13, 2025 | Data, Eco/Invest/Demography, Health
India is known as the diabetes capital of the world with over 10 crore people diagnosed with the lifestyle disease, as per the Indian Council of Medical Research–India Diabetes (ICMR INDIAB) study in 2023 New Delhi: The price of commonly used diabetes drug...
by AIP Online Bureau | Dec 16, 2024 | Data, Eco/Invest/Demography, Health
The biobank will facilitate advanced research on the causes of diabetes, the variations of the Indian type of diabetes and related disorders, said Dr V Mohan, chairman of the MDRF and Dr Mohan’s Diabetes Specialities Centre The country’s first diabetes...
by AIP Online Bureau | Nov 14, 2024 | Data, Eco/Invest/Demography, Health
Of the 82.8 crore, India’s share formed over a quarter (21.2 crore). Another 14.8 crore were in China, while 4.2 crore, 3.6 crore and 2.2 crore lived in the US, Pakistan and Brazil, respectively, the researchers found New Delhi: About 82.8 crore people around...
